Evidence map›Paper›PMID 42824021›Full record

ArticleFrontiers in ophthalmology2026

Emerging mechanisms in dry eye disease: apoptosis-associated tear MicroRNAs and toxicant-related alterations of the glycocalyx and lipid rafts.

Mazyar Yazdani

Abstract read
In one paragraph

Article in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mazyar YazdaniDepartment of Medical Biochemistry, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dry eye disease (DED), a multifactorial condition of the ocular surface, is marked by disruption of tear film homeostasis that can result in ocular discomfort, visual impairment, and potential epithelial damage. Its high prevalence and impact on quality of life and healthcare utilization underscore the need to better understand its underlying mechanisms. Although current research has clarified several key contributors, including tear film instability, ocular surface inflammation, and neural dysfunction, the complex pathophysiology of DED remains only partly understood. Moreover, new mechanistic insights are needed to advance diagnostic and therapeutic approaches. Hypothesis: This article highlights three emerging and underexplored mechanisms that may contribute to DED, based on a combination of disease-associated observations, indirect evidence, and mechanistic inference: (i) apoptosis-related tear microRNAs (miRNAs) as potential regulators of epithelial damage, (ii) ocular surface glycocalyx alterations potentially associated with environmental pollutants, and (iii) lipid raft disruption as a plausible mediator of toxicant-induced responses in ocular surface cells. Supporting evidence: First, apoptosis-related miRNAs in tears, traditionally viewed as potential biomarkers of the disease, are discussed as candidate regulators of epithelial damage through modulation of apoptotic pathways, although direct evidence in DED causation/development remains limited. Second, glycocalyx alterations potentially associated with environmental pollutants, such as airborne nanoparticles and reactive volatile compounds, are considered. This consideration draws in part on findings from non-ocular and non-DED systems. Third, lipid raft disruption is presented as a plausible but as yet untested mechanism in the context of the ocular surface and DED, potentially linking toxicant exposure to downstream cellular responses. Conclusion: By distinguishing between established knowledge, disease-associated findings, and forward-looking hypotheses, this work aims to broaden current perspectives on DED pathophysiology and suggest novel directions for future research.

Indexed as

apoptosisdry eye diseaseenvironmental toxicantsglycocalyx alterationshaptenationlipid raft disruptionnanoparticlestear microRNAs

Identifiers

PMID42824021
PMCPMC13627036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.